LexaGene (CVE:LXG) Shares Down 19.2% – Here’s What Happened

LexaGene Holdings Inc. (CVE:LXGGet Free Report) shares fell 19.2% during mid-day trading on Wednesday . The company traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares traded hands during mid-day trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.

LexaGene Stock Performance

The firm has a fifty day moving average price of C$0.11 and a 200 day moving average price of C$0.11. The company has a current ratio of 1.39, a quick ratio of 1.13 and a debt-to-equity ratio of 138.01. The firm has a market cap of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26.

About LexaGene

(Get Free Report)

LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.

Featured Stories

Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.